Heather Walker
0000-0002-8015-4071
Dana-Farber Cancer Institute
1 paper found
Refreshing results…
A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia
Missing publications? Search for publications with a matching author name.